SCHEMBL2451003

SCHEMBL2451003

CS[C@H](C)[C@H](N)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL342124 1.00
SCHEMBL16181947 0.85 SLC7A5 (0.50)
SCHEMBL6684752 0.81 SLC7A5 (0.57)
SCHEMBL2313042 0.79 SLC7A5 (0.55)
SCHEMBL16300972 0.77
SCHEMBL16490238 0.77
Valine SCHEMBL9321177 0.76 SLC7A5 (0.83)
Valine SCHEMBL628974 0.75 SLC7A5 (0.94)
Valine SCHEMBL135483 0.75
Valine SCHEMBL4078935 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3009504-B1 MICROORGANISM PRODUCING L-ISOLEUCINE AND METHOD FOR PREPARING L-ISOLEUCINE USING THE SAME CJ CHEILJEDANG CORP (KR) 2020-12-02 EP claimed
US-20160145699-A1 L-ISOLEUCINE-PRODUCING MICROORGANISM AND METHOD OF PRODUCING L-ISOLEUCINE USING THE SAME CJ CHEILJEDANG CORPORATION (KR) 2016-05-26 US claimed
EP-3009504-A1 MICROORGANISM PRODUCING L-ISOLEUCINE AND METHOD FOR PREPARING L-ISOLEUCINE USING SAME Cj Cheiljedang Corporation (KR) 2016-04-20 EP claimed
WO-2014200126-A1 MICROORGANISM PRODUCING L-ISOLEUCINE AND METHOD FOR PREPARING L-ISOLEUCINE USING SAME 씨제이제일제당 (주) (KR) 2014-12-18 WO claimed
US-12590128-B2 Acetohydroxy acid synthase variant and microorganism including the same CJ CHEILJEDANG CORPORATION (KR) 2026-03-31 US disclosed
EP-4661892-A1 TNF-ALPHA BINDING AGENTS AND METHODS OF USING THE SAME Navigen, Inc. (US) 2025-12-17 EP disclosed
EP-4441070-A1 MODIFIED AMATOXINS AND USES THEREOF The University of British Columbia (CA) 2024-10-09 EP disclosed
WO-2024168055-A1 TNF-ALPHA BINDING AGENTS AND METHODS OF USING THE SAME NAVIGEN, INC. (US) 2024-08-15 WO disclosed
EP-3272860-B1 PYRUVATE DEHYDROGENASE MUTANT, MICROORGANISM COMPRISING MUTANT, AND METHOD FOR PRODUCING L-AMINO ACID BY USING MICROORGANISM CJ CHEILJEDANG CORP (KR) 2023-08-09 EP disclosed
US-20230203106-A1 NOVEL ACETOHYDROXY ACID SYNTHASE VARIANT AND MICROORGANISM INCLUDING THE SAME CJ CHEILJEDANG CORPORATION (KR) 2023-06-29 US disclosed
WO-2023097407-A1 MODIFIED AMATOXINS AND USES THEREOF THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2023-06-08 WO disclosed
EP-4023751-A1 NOVEL ACETOHYDROXYACID SYNTHASE VARIANT AND MICROGRANISMS COMPRISING SAME CJ Cheiljedang Corporation (KR) 2022-07-06 EP disclosed
WO-1999047154-A1 DIPEPTIDE CASPASE INHIBITORS AND THE USE THEREOF CYTOVIA, INC. (US) 1999-09-23 WO disclosed
US-5939458-A APPLYING AN INHIBITOR OF AMINOACYL-TRNA SYNTHETASE TO THE SKIN GILLETTE COMPANY, THE 1999-08-17 US disclosed
WO-1999015136-A1 REDUCTION OF HAIR GROWTH THE GILLETTE COMPANY (US) 1999-04-01 WO disclosed
WO-1999012970-A1 PEPTIDES CONTAINING AN ARGININE MIMETIC FOR THE TREATMENT OF BONE METABOLIC DISORDERS, THEIR PRODUCTION, AND DRUGS CONTAINING THESE COMPOUNDS ROCHE DIAGNOSTICS GMBH (DE) 1999-03-18 WO disclosed
EP-0902036-A1 Peptide containing an arginine mimetic for the treatment of osteoporosis, their production, and drugs containing these compounds Roche Diagnostics GmbH (DE) 1999-03-17 EP disclosed
WO-1998058915-A2 PYRIMIDIN-2,4,6-TRION DERIVATIVES AND THEIR USE AS METALLOPROTEASE-INHIBITORS ROCHE DIAGNOSTICS GMBH (DE) 1998-12-30 WO disclosed
US-5518906-A MUTANT ESCHERICHIA MICROBE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-05-21 US disclosed
EP-0590857-A2 Production of D-pantoic acid and D-pantothenic acid TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-04-06 EP disclosed